StonvexLoading…
StonvexStonvexStonvexCore line items from PACS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.42B | $5.29B | $3.93B | $2.59B |
Operating Income | $120.03M | $309.60M | $214.91M | $128.64M |
Net Income | $80.69M | $191.54M | $131.84M | $79.44M |
EPS (Diluted) | $0.50 | $1.22 | $0.80 | $0.48 |
Total Assets | $5.66B | $5.58B | $5.63B | $5.50B |
Total Liabilities | $4.62B | $4.63B | $4.75B | $4.69B |
Cash & Equivalents | $247.98M | $197.02M | $355.67M | $294.17M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 157.17M | 156.62M | 156.62M | 156.57M |